KKR Acquires Controlling Stake in Singapore Education Operator for $1.3B

BenzingaBenzinga
|||1 min read
Key Takeaway

KKR acquires controlling stake in Singapore education operator XCL Education Holdings for $1.3 billion, marking its entry into Asia-Pacific education sector.

KKR Acquires Controlling Stake in Singapore Education Operator for $1.3B

KKR has secured a controlling stake in XCL Education Holdings, a Singapore-based kindergarten-through-12th-grade education provider, in a transaction valued at approximately $1.3 billion on an enterprise value basis. The acquisition represents KKR's entry into the Asia-Pacific education sector and marks a strategic expansion of its portfolio within the region's growing education market.

TPG, the current majority shareholder, is divesting its stake in the educational institution operator following a competitive bidding process. KKR prevailed over several rival bidders, including Warburg Pincus, Blackstone, and EQT AB, to secure the transaction. The outcome reflects continued investor interest in education-focused businesses, particularly in developed Asia-Pacific markets with strong demographic and economic fundamentals.

The transaction is anticipated to close subject to customary regulatory approvals and closing conditions. Upon completion, the deal will expand KKR's presence in the education sector and diversify its Asia-focused investment activities. Financial details regarding the transaction structure and debt components have not been disclosed.

Source: Benzinga

Back to newsPublished Feb 23

Related Coverage

Benzinga

Mountain Commerce Bancorp Clears Regulatory Hurdles for Home BancShares Merger

Mountain Commerce Bancorp receives Federal Reserve and Arkansas regulatory approvals for merger with Home BancShares, expected to close in early Q2 2026.

HOMBMCBI
Benzinga

Smithfield Foods Surges on Robust Q4 Earnings, Nathan's Famous Deal

Smithfield Foods beat Q4 expectations with 83-cent EPS, announced $450M Nathan's Famous acquisition at $102/share, projecting $1.3-$1.5B FY26 operating profit. Stock surged 4.13%.

SFDNATH
Benzinga

Gilead Bolsters Inflammation Arsenal With $1.675B Ouro Medicines Deal

Gilead acquires Ouro Medicines for $1.675B upfront, targeting inflammation pipeline expansion. Galapagos NV partners to co-develop lead asset OM336.

GILDACLXGLPG
Benzinga

Vertiv Accelerates Capacity Push to Capitalize on AI Data Center Boom

Vertiv expands manufacturing capacity across three facilities and acquires ThermoKey to meet soaring AI data center demand for cooling and power infrastructure.

VRTAIPO
Benzinga

SEALSQ to Acquire Quantum Interconnect Firm Miraex in Strategic Stack Play

SEALSQ signs Letter of Intent to acquire Swiss quantum interconnect firm Miraex, completing its quantum technology stack and supporting space-based quantum infrastructure initiative.

LAESWKEY
Benzinga

VGTEL Eyes Health-Tech Acquisition From 4biddenknowledge in Strategic Bell Rose Deal

VGTEL enters formal discussions with Bell Rose Capital to acquire a pre-revenue health-tech app, with due diligence underway and potential advisory role for Bell Rose's president.

VGTLBELR